CIBC World Market
NTLA icon

CIBC World Market’s Intellia Therapeutics NTLA Stock Holding History

CIBC World Market’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,478
Closed -$108K – 1458
2025
Q2 		$108K Sell
11,478
-7,042
-38% -$57.8K ﹤0.01% 1316
2025
Q1 		$132K Sell
18,520
-1,543
-8% -$15.6K ﹤0.01% 1295
2024
Q4 		$234K Buy
20,063
+3,657
+22% +$57.1K ﹤0.01% 1255
2024
Q3 		$337K Sell
16,406
-1,695
-9% -$39.1K ﹤0.01% 1105
2024
Q2 		$405K Sell
18,101
-2,136
-11% -$50.9K ﹤0.01% 1019
2024
Q1 		$557K Buy
20,237
+359
+2% +$9.97K ﹤0.01% 957
2023
Q4 		$606K Buy
19,878
+4,479
+29% +$129K ﹤0.01% 893
2023
Q3 		$487K Buy
15,399
+876
+6% +$34K ﹤0.01% 906
2023
Q2 		$592K Buy
14,523
+6,791
+88% +$275K ﹤0.01% 885
2023
Q1 		$288K Sell
7,732
-765
-9% -$30K ﹤0.01% 1057
2022
Q4 		$296K Buy
8,497
+453
+6% +$21.5K ﹤0.01% 1067
2022
Q3 		$450K Sell
8,044
-990
-11% -$61.4K ﹤0.01% 911
2022
Q2 		$468K Buy
9,034
+4,294
+91% +$218K ﹤0.01% 895
2022
Q1 		$344K Buy
4,740
+1,522
+47% +$129K ﹤0.01% 1048
2021
Q4 		$380K Buy
3,218
+752
+30% +$94.2K ﹤0.01% 1055
2021
Q3 		$331K Sell
2,466
-696
-22% -$105K ﹤0.01% 1101
2021
Q2 		$512K Sell
3,162
-2,098
-40% -$163K ﹤0.01% 983
2021
Q1 		$422K Buy
+5,260
New +$353K ﹤0.01% 1004

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC World Market's NTLA Position: Q3 2025 in Review

CIBC World Market sold out of Intellia Therapeutics (NTLA) in Q3 2025, closing a stake of 11,478 shares — an estimated $108K sold.

CIBC World Market first reported a position in NTLA in Q1 2021 and held it in 18 quarters. The position peaked at $606K in Q4 2023. 282 funds tracked by Wall St. Rank hold NTLA as of Q3 2025.

  • CIBC World Market reported no remaining Intellia Therapeutics position as of Q3 2025 after selling out during the quarter.
  • CIBC World Market sold 11,478 Intellia Therapeutics shares in Q3 2025, an estimated $108K.
  • CIBC World Market first reported a position in Intellia Therapeutics in Q1 2021 and held it in 18 quarters.
  • CIBC World Market's Intellia Therapeutics position peaked at $606K in Q4 2023.
  • 282 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2025.

Based on CIBC World Market's 13F filing for Q3 2025, filed 6 Nov 2025.